The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics
Abstract
:1. Introduction
1.1. An Overview of Gastrointestinal Cancers
1.2. The Gut Microbiota and GI Cancers
1.3. Current Challenges with GI Cancer Treatment and Prevention
2. Brassicaceae in Cancer Prevention and Treatment
2.1. Brassicaceae Species
2.2. Brassicaceae Bioactive Compounds
2.3. Brassicaceae Phytoproducts as Anti-Cancer Therapeutics
2.4. The Role of Brassicaceae in the Prevention of Gastrointestinal Tumours
3. Technological Strategies to Improve Stability and Bioefficacy of Cruciferous Vegetables after Oral Ingestion
4. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Weng, M.T.; Chiu, Y.T.; Wei, P.Y.; Chiang, C.W.; Fang, H.L.; Wei, S. Microbiota and gastrointestinal cancer. J. Formos. Med. Assoc. 2019, 118, S32–S41. [Google Scholar] [CrossRef]
- Meng, C.; Bai, C.; Brown, T.D.; Hood, L.E.; Tian, Q. Human Gut Microbiota and Gastrointestinal Cancer. Genom. Proteom. Bioinform. 2018, 16, 33–49. [Google Scholar] [CrossRef] [PubMed]
- Cheng, L.K.; O’Grady, G.; Du, P.; Egbuji, J.U.; Windsor, J.A.; Pullan, A.J. Gastrointestinal system. Wiley Inderdiscip Rev. Syst. Biol. Med. 2010, 2, 65–79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bijlsma, M.F.; Sadanandam, A.; Tan, P.; Vermeulen, L. Molecular subtypes in cancers of the gastrointestinal tract. Nat. Rev. Gastroenterol. Hepatol. 2017, 14, 333–342. [Google Scholar] [CrossRef] [PubMed]
- Fitzmaurice, C.; Abate, D.; Abbasi, N.; Abbastabar, H.; Abd-Allah, F.; Abdel-Rahman, O.; Abdelalim, A.; Abdoli, A.; Abdollahpour, I.; Abdulle, A.S.M.; et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 2019, 5, 1749–1768. [Google Scholar] [CrossRef] [Green Version]
- Soleimanpour, S.; Hasanian, S.M.; Avan, A.; Yaghoubi, A.; Khazaei, M. Bacteriotherapy in gastrointestinal cancer. Life Sci. 2020, 254, 117754. [Google Scholar] [CrossRef]
- Saraiva, R.; Perkusich, M.; Silva, L.; Almeida, H.; Siebra, C.; Perkusich, A. Early diagnosis of gastrointestinal cancer by using case-based and rule-based reasoning. Expert Syst. Appl. 2016, 61, 192–202. [Google Scholar] [CrossRef]
- Yu, J.; Zhao, J.; Zhang, M.; Guo, J.; Liu, X.; Liu, L. Metabolomics studies in gastrointestinal cancer: A systematic review. Expert Rev. Gastroenterol. Hepatol. 2020, 14, 9–25. [Google Scholar] [CrossRef] [PubMed]
- Globocan. Colorectal Cancer Incidence in The World. Glob. Cancer Obs. 2020, 419, 1–2. [Google Scholar]
- Keller, D.S.; Berho, M.; Perez, R.O.; Wexner, S.D.; Chand, M. The multidisciplinary management of rectal cancer. Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 414–429. [Google Scholar] [CrossRef]
- Keum, N.N.; Giovannucci, E. Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 713–732. [Google Scholar] [CrossRef] [PubMed]
- Wong, S.H.; Yu, J. Gut microbiota in colorectal cancer: Mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 690–704. [Google Scholar] [CrossRef] [PubMed]
- O’Keefe, S.J.D. Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 2016, 13, 691–706. [Google Scholar] [CrossRef] [PubMed]
- Sánchez-Alcoholado, L.; Ramos-Molina, B.; Otero, A.; Laborda-Illanes, A.; Ordóñez, R.; Medina, J.A.; Gómez-Millán, J.; Queipo-Ortuño, M.I. The role of the gut microbiome in colorectal cancer development and therapy response. Cancers 2020, 12, 1406. [Google Scholar] [CrossRef]
- Marengo, A.; Rosso, C.; Bugianesi, E. Liver cancer: Connections with obesity, fatty liver, and cirrhosis. Annu. Rev. Med. 2016, 67, 103–117. [Google Scholar] [CrossRef]
- Zhou, Y.; Li, Y.; Zhou, T.; Zheng, J.; Li, S.; Li, H. Dietary natural products for prevention and treatment of liver cancer. Nutrients 2016, 8, 156. [Google Scholar] [CrossRef] [Green Version]
- Sia, D.; Villanueva, A.; Friedman, S.L.; Llovet, J.M. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis. Gastroenterology 2017, 152, 745–761. [Google Scholar] [CrossRef] [Green Version]
- Anwanwan, D.; Singh, S.K.; Singh, S.; Saikam, V.; Singh, R. Challenges in liver cancer and possible treatment approaches. Biochim. Biophys. Acta Rev. Cancer 2020, 1873, 188314. [Google Scholar] [CrossRef]
- Bruix, J.; Han, K.H.; Gores, G.; Llovet, J.M.; Mazzaferro, V. Liver cancer: Approaching a personalized care. J. Hepatol. 2015, 62 (Suppl. 1), S144–S156. [Google Scholar] [CrossRef] [Green Version]
- den Hoed, C.M.; Kuipers, E.J. Gastric Cancer: How Can We Reduce the Incidence of this Disease? Curr. Gastroenterol. Rep. 2016, 18, 1–8. [Google Scholar] [CrossRef] [Green Version]
- Smyth, E.C.; Nilsson, M.; Grabsch, H.I.; van Grieken, N.C.; Lordick, F. Gastric cancer. Lancet 2020, 396, 635–648. [Google Scholar] [CrossRef]
- Song, Z.; Wu, Y.; Yang, J.; Yang, D.; Fang, X. Progress in the treatment of advanced gastric cancer. Tumor Biol. 2017, 39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Johnson, I.T. Cruciferous Vegetables and Risk of Cancers of the Gastrointestinal Tract. Mol. Nutr. Food Res. 2018, 62, 1701000. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Johnston, F.M.; Beckman, M. Updates on Management of Gastric Cancer. Curr. Oncol. Rep. 2019, 21, 67. [Google Scholar] [CrossRef] [PubMed]
- Van Cutsem, E.; Sagaert, X.; Topal, B.; Haustermans, K.; Prenen, H. Gastric cancer. Lancet 2016, 388, 2654–2664. [Google Scholar] [CrossRef]
- Bollschweiler, E.; Plum, P.; Mönig, S.P.; Hölscher, A.H. Current and future treatment options for esophageal cancer in the elderly. Expert Opin. Pharmacother. 2017, 18, 1001–1010. [Google Scholar] [CrossRef]
- Kelly, R.J. Emerging multimodality approaches to treat localized esophageal cancer. JNCCN J. Natl. Compr. Cancer Netw. 2019, 17, 1009–1014. [Google Scholar] [CrossRef] [Green Version]
- Huang, F.L.; Yu, S.J. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J. Surg. 2018, 41, 210–215. [Google Scholar] [CrossRef]
- Arnal, M.J.D.; Arenas, Á.F.; Arbeloa, Á.L. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J. Gastroenterol. 2015, 21, 7933–7943. [Google Scholar] [CrossRef]
- Kato, H.; Nakajima, M. Treatments for esophageal cancer: A review. Gen. Thorac. Cardiovasc. Surg. 2013, 61, 330–335. [Google Scholar] [CrossRef]
- Walker, R.C.; Underwood, T.J. Esophageal cancer. Surgery 2020, 38, 702–710. [Google Scholar] [CrossRef]
- Chu, L.C.; Goggins, M.G.; Fishman, E.K. Diagnosis and detection of pancreatic cancer. Cancer J. 2017, 23, 333–342. [Google Scholar] [CrossRef]
- Gupta, R.; Amanam, I.; Chung, V. Current and future therapies for advanced pancreatic cancer. J. Surg. Oncol. 2017, 116, 25–34. [Google Scholar] [CrossRef]
- Ilic, M.; Ilic, I. Epidemiology of pancreatic cancer. World J. Gastroenterol. 2016, 22, 9694–9705. [Google Scholar] [CrossRef]
- Ansari, D.; Tingstedt, B.; Andersson, B.; Holmquist, F.; Sturesson, C.; Williamsson, C.; Sasor, A.; Borg, D.; Bauden, M.; Andersson, R. Pancreatic cancer: Yesterday, today and tomorrow. Future Oncol. 2016, 12, 1929–1946. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goral, V. Pancreatic cancer: Pathogenesis and diagnosis. Asian Pac. J. Cancer Prev. 2015, 16, 5619–5624. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fan, Y.; Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 2020, 19, 55–71. [Google Scholar] [CrossRef] [PubMed]
- Garrett, W.S. The gut microbiota and colon cancer. Science 2019, 364, 1133–1135. [Google Scholar] [CrossRef] [PubMed]
- Lynch, S.V.; Pedersen, O. The Human Intestinal Microbiome in Health and Disease. N. Engl. J. Med. 2016, 375, 2369–2379. [Google Scholar] [CrossRef] [Green Version]
- Vivarelli, S.; Salemi, R.; Candido, S.; Falzone, L.; Santagati, M.; Stefani, S.; Torino, F.; Banna, G.L.; Tonini, G.; Libra, M. Gut microbiota and cancer: From pathogenesis to therapy. Cancers 2019, 11, 38. [Google Scholar] [CrossRef] [Green Version]
- Kong, F.; Cai, Y. Study Insights into Gastrointestinal Cancer through the Gut Microbiota. BioMed Res. Int. 2019, 11, 38. [Google Scholar] [CrossRef]
- Rossi, T.; Vergara, D.; Fanini, F.; Maffia, M.; Bravaccini, S.; Pirini, F. Microbiota-derived metabolites in tumor progression and metastasis. Int. J. Mol. Sci. 2020, 21, 5786. [Google Scholar] [CrossRef]
- Whisner, C.M.; Aktipis, C.A. The Role of the Microbiome in Cancer Initiation and Progression: How Microbes and Cancer Cells Utilize Excess Energy and Promote One Another’s Growth. Curr. Nutr. Rep. 2019, 8, 42–51. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Javanmard, A.; Ashtari, S.; Sabet, B.; Davoodi, S.H.; Rostami-Nejad, M.; Esmaeil-Akbari, M.; Niaz, A.; Mortazavian, A.M. Probiotics and their role in gastrointestinal cancers prevention and treatment—An overview. Gastroenterol. Hepatol. Bed Bench 2018, 11, 284–295. [Google Scholar] [CrossRef] [PubMed]
- Shoaf, K.; Mulvey, G.L.; Armstrong, G.D.; Hutkins, R.W. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect. Immun. 2006, 74, 6920–6928. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Monteagudo-Mera, A.; Rastall, R.A.; Gibson, G.R.; Charalampopoulos, D.; Chatzifragkou, A. Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl. Microbiol. Biotechnol. 2019, 103, 6463–6472. [Google Scholar] [CrossRef] [Green Version]
- Fong, W.; Li, Q.; Yu, J. Gut microbiota modulation: A novel strategy for prevention and treatment of colorectal cancer. Oncogene 2020, 39, 4925–4943. [Google Scholar] [CrossRef]
- Buckley, A.M.; Lynam-Lennon, N.; O’Neill, H.; O’Sullivan, J. Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers. Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 298–313. [Google Scholar] [CrossRef]
- Langer, R.; Becker, K. Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy. Virchows Arch. 2018, 472, 175–186. [Google Scholar] [CrossRef]
- Franzke, A.; Lysak, M.A.; Al-Shehbaz, I.A.; Koch, M.A.; Mummenhoff, K. Cabbage family affairs: The evolutionary history of Brassicaceae. Trends Plant Sci. 2011, 16, 108–116. [Google Scholar] [CrossRef]
- Nikolov, L.A. Brassicaceae flowers: Diversity amid uniformity. J. Exp. Bot. 2019, 70, 2623–2635. [Google Scholar] [CrossRef] [PubMed]
- Šamec, D.; Salopek-Sondi, B. Cruciferous (brassicaceae) vegetables. Nonvitamin Nonmineral Nutr. Suppl. 2018, 195–202. [Google Scholar] [CrossRef]
- Mandrich, L.; Caputo, E. Brassicaceae-derived anti-cancer agents: Towards a green approach to beat cancer. Nutrients 2020, 12, 868. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Avato, P.; Argentieri, M.P. Brassicaceae: A rich source of health improving phytochemicals. Phytochem. Rev. 2015, 14, 1019–1033. [Google Scholar] [CrossRef]
- Björkman, M.; Klingen, I.; Birch, A.N.E.; Bones, A.M.; Bruce, T.J.A.; Johansen, T.J.; Meadow, R.; Mølmann, J.; Seljåsen, R.; Smart, L.E.; et al. Phytochemicals of Brassicaceae in plant protection and human health—Influences of climate, environment and agronomic practice. Phytochemistry 2011, 72, 538–556. [Google Scholar] [CrossRef] [PubMed]
- Raiola, A.; Errico, A.; Petruk, G.; Monti, D.M.; Barone, A.; Rigano, M.M. Bioactive compounds in brassicaceae vegetables with a role in the prevention of chronic diseases. Molecules 2018, 23, 15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jahangir, M.; Kim, H.K.; Choi, Y.H.; Verpoorte, R. Health-Affecting Compounds in Brassicaceae. Compr. Rev. Food Sci. Food Saf. 2009, 8, 31–43. [Google Scholar] [CrossRef]
- Ramirez, D.; Abellán-Victorio, A.; Beretta, V.; Camargo, A.; Moreno, D.A. Functional ingredients from brassicaceae species: Overview and perspectives. Int. J. Mol. Sci. 2020, 21, 1998. [Google Scholar] [CrossRef] [Green Version]
- Singh, J.; Upadhyay, A.K.; Prasad, K.; Bahadur, A.; Rai, M. Variability of carotenes, vitamin C, E and phenolics in Brassica vegetables. J. Food Compos. Anal. 2007, 20, 106–112. [Google Scholar] [CrossRef]
- Favela-González, K.M.; Hernández-Almanza, A.Y.; De la Fuente-Salcido, N.M. The value of bioactive compounds of cruciferous vegetables (Brassica) as antimicrobials and antioxidants: A review. J. Food Biochem. 2020, 44, e13414. [Google Scholar] [CrossRef]
- Saban, G.M. The Benefits of Brassica Vegetables on Human Health. J. Hum. Health Res. 2018, 1, 104. [Google Scholar]
- Long, J.; Guan, P.; Hu, X.; Yang, L.; He, L.; Lin, Q.; Luo, F.; Li, J.; He, X.; Du, Z.; et al. Natural Polyphenols as Targeted Modulators in Colon Cancer: Molecular Mechanisms and Applications. Front. Immunol. 2021, 12, 635484. [Google Scholar] [CrossRef] [PubMed]
- Shen, X.; Si, Y.; Wang, Z.; Wang, J.; Guo, Y.; Zhang, X. Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K/Akt signaling. Int. J. Mol. Med. 2016, 38, 619–626. [Google Scholar] [CrossRef] [PubMed]
- Ekström, A.M.; Serafini, M.; Nyrén, O.; Wolk, A.; Bosetti, C.; Bellocco, R. Dietary quercetin intake and risk of gastric cancer: Results from a population-based study in Sweden. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2011, 22, 438–443. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.W.; Zhang, H.; Liang, X.; Ong, C.N. Simultaneous determination of carotenoids, tocopherols and phylloquinone in 12 Brassicaceae vegetables. LWT 2020, 130, 109649. [Google Scholar] [CrossRef]
- Niranjana, R.; Gayathri, R.; Nimish Mol, S.; Sugawara, T.; Hirata, T.; Miyashita, K.; Ganesan, P. Carotenoids modulate the hallmarks of cancer cells. J. Funct. Foods 2015, 18, 968–985. [Google Scholar] [CrossRef]
- Chen, Q.H.; Wu, B.K.; Pan, D.; Sang, L.X.; Chang, B. Beta-carotene and its protective effect on gastric cancer. World J. Clin. Cases 2021, 9, 6591–6607. [Google Scholar] [CrossRef]
- Park, Y.; Lee, H.; Lim, J.W.; Kim, H. Inhibitory Effect of β-Carotene on Helicobacter pylori-Induced TRAF Expression and Hyper-Proliferation in Gastric Epithelial Cells. Antioxidants 2019, 8, 637. [Google Scholar] [CrossRef] [Green Version]
- Kim, J.H.; Lee, J.; Choi, I.J.; Kim, Y.I.; Kwon, O.; Kim, H.; Kim, J. Dietary Carotenoids Intake and the Risk of Gastric Cancer: A Case-Control Study in Korea. Nutrients 2018, 10, 1031. [Google Scholar] [CrossRef] [Green Version]
- Ishida, M.; Hara, M.; Fukino, N.; Kakizaki, T.; Morimitsu, Y. Glucosinolate metabolism, functionality and breeding for the improvement of brassicaceae vegetables. Breed. Sci. 2014, 64, 48–59. [Google Scholar] [CrossRef] [Green Version]
- Halkier, B.A.; Gershenzon, J. Biology and biochemistry of glucosinolates. Annu. Rev. Plant Biol. 2006, 57, 303–333. [Google Scholar] [CrossRef] [Green Version]
- Bell, L.; Oloyede, O.O.; Lignou, S.; Wagstaff, C.; Methven, L. Taste and Flavor Perceptions of Glucosinolates, Isothiocyanates, and Related Compounds. Mol. Nutr. Food Res. 2018, 62, 1700990. [Google Scholar] [CrossRef] [Green Version]
- Zhou, Q.; Tang, H.; Jia, X.; Zheng, C.; Huang, F.; Zhang, M. Distribution of glucosinolate and pungent odors in rapeseed oils from raw and microwaved seeds. Int. J. Food Prop. 2018, 21, 2296–2308. [Google Scholar] [CrossRef] [Green Version]
- Park, J.E.; Sun, Y.; Lim, S.K.; Tam, J.P.; Dekker, M.; Chen, H.; Sze, S.K. Dietary phytochemical PEITC restricts tumor development via modulation of epigenetic writers and erasers. Sci. Rep. 2017, 7, 40569. [Google Scholar] [CrossRef] [Green Version]
- Pappa, G.; Lichtenberg, M.; Iori, R.; Barillari, J.; Bartsch, H.; Gerhäuser, C. Comparison of growth inhibition profiles and mechanisms of apoptosis induction in human colon cancer cell lines by isothiocyanates and indoles from Brassicaceae. Mutat. Res. Fundam. Mol. Mech. Mutagenes. 2006, 599, 76–87. [Google Scholar] [CrossRef]
- Thangam, R.; Suresh, V.; Rajkumar, M.; Vincent, J.D.; Gunasekaran, P.; Anbazhagan, C.; Kaveri, K.; Kannan, S. Antioxidant and In Vitro Anticancer Effect of 2-Pyrrolidinone Rich Fraction of Brassica oleracea var. capitata Through Induction of Apoptosis in Human Cancer Cells. Phytother. Res. PTR 2013, 27, 1664–1670. [Google Scholar] [CrossRef] [PubMed]
- Cheng, A.C.; Shen, C.J.; Hung, C.M.; Hsu, Y.C. Sulforaphane Decrease of SERTAD1 Expression Triggers G1/S Arrest in Breast Cancer Cells. J. Med. Food 2019, 22, 444–450. [Google Scholar] [CrossRef]
- Kan, S.F.; Wang, J.; Sun, G.X. Sulforaphane regulates apoptosis- and proliferation-related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer. Int. J. Mol. Med. 2018, 42, 2447–2458. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kallifatidis, G.; Labsch, S.; Rausch, V.; Mattern, J.; Gladkich, J.; Moldenhauer, G.; Büchler, M.W.; Salnikov, A.V.; Herr, I. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol. Ther. J. Am. Soc. Gene Ther. 2011, 19, 188–195. [Google Scholar] [CrossRef] [PubMed]
- Martelli, A.; Piragine, E.; Citi, V.; Testai, L.; Pagnotta, E.; Ugolini, L.; Lazzeri, L.; Di Cesare Mannelli, L.; Manzo, O.L.; Bucci, M.; et al. Erucin exhibits vasorelaxing effects and antihypertensive activity by H2 S-releasing properties. Br. J. Pharmacol. 2020, 177, 824–835. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Deer, E.L.; González-Hernández, J.; Coursen, J.D.; Shea, J.E.; Ngatia, J.; Scaife, C.L.; Firpo, M.A.; Mulvihill, S.J. Phenotype and genotype of pancreatic cancer cell lines. Pancreas 2010, 39, 425–435. [Google Scholar] [CrossRef] [Green Version]
- Citi, V.; Piragine, E.; Pagnotta, E.; Ugolini, L.; Di Cesare Mannelli, L.; Testai, L.; Ghelardini, C.; Lazzeri, L.; Calderone, V.; Martelli, A. Anticancer properties of erucin, an H 2 S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1). Phytother. Res. 2019, 33, 845–855. [Google Scholar] [CrossRef] [Green Version]
- Ohara, M.; Kimura, S.; Tanaka, A.; Ohnishi, K.; Okayasu, R.; Kubota, N. Benzyl isothiocyanate sensitizes human pancreatic cancer cells to radiation by inducing apoptosis. Int. J. Mol. Med. 2011, 28, 1043–1047. [Google Scholar] [CrossRef]
- Lamy, E.; Hertrampf, A.; Herz, C.; Schüler, J.; Erlacher, M.; Bertele, D.; Bakare, A.; Wagner, M.; Weiland, T.; Lauer, U.; et al. Preclinical Evaluation of 4-Methylthiobutyl Isothiocyanate on Liver Cancer and Cancer Stem Cells with Different p53 Status. PLoS ONE 2013, 8, e70846. [Google Scholar]
- Kim, S.M. Cellular and Molecular Mechanisms of 3,3′-Diindolylmethane in Gastrointestinal Cancer. Int. J. Mol. Sci. 2016, 17, 1155. [Google Scholar] [CrossRef] [Green Version]
- Ye, Y.; Fang, Y.; Xu, W.; Wang, Q.; Zhou, J.; Lu, R. 3,3′-Diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy. Biochem. Pharmacol. 2016, 115, 77–84. [Google Scholar] [CrossRef] [PubMed]
- Liu, T.; Zhang, L.; Joo, D.; Sun, S.C. NF-κB signaling in inflammation. Signal Transduct. Target. Ther. 2017, 2, 17023. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Youn, H.S.; Kim, Y.S.; Park, Z.Y.; Kim, S.Y.; Choi, N.Y.; Joung, S.M.; Seo, J.A.; Lim, K.M.; Kwak, M.K.; Hwang, D.H.; et al. Sulforaphane Suppresses Oligomerization of TLR4 in a Thiol-Dependent Manner. J. Immunol. 2010, 184, 411–419. [Google Scholar] [CrossRef] [Green Version]
- Fuentes, F.; Paredes-Gonzalez, X.; Kong, A.N.T. Dietary Glucosinolates Sulforaphane, Phenethyl Isothiocyanate, Indole-3-Carbinol/3,3′-Diindolylmethane: Anti-Oxidative Stress/Inflammation, Nrf2, Epigenetics/Epigenomics and In Vivo Cancer Chemopreventive Efficacy. Curr. Pharm. Rep. 2015, 1, 179–196. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sturm, C.; Wagner, A.E. Brassica-derived plant bioactives as modulators of chemopreventive and inflammatory signaling pathways. Int. J. Mol. Sci. 2017, 18, 1890. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, Y.J.; Wallig, M.A.; Jeffery, E.H. Dietary broccoli lessens development of fatty liver and liver cancer in mice given diethylnitrosamine and fed a western or control diet. J. Nutr. 2016, 146, 542–550. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, H.; Khor, T.O.; Shu, L.; Su, Z.Y.; Fuentes, F.; Lee, J.H.; Kong, A.N. Plants vs. cancer: A review on natural phytochemicals in preventing and treating cancers and their druggability. Anti-Cancer Agents Med. Chem. 2012, 12, 1281–1305. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.; Jo, D.G.; Park, D.; Chung, H.Y.; Mattson, M.P. Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: Focus on the nervous system. Pharmacol. Rev. 2014, 66, 815–868. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ahmed, S.M.; Luo, L.; Namani, A.; Wang, X.J.; Tang, X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim. Et Biophys. Acta. Mol. Basis Dis. 2017, 1863, 585–597. [Google Scholar] [CrossRef] [PubMed]
- Kaufman-Szymczyk, A.; Majewski, G.; Lubecka-Pietruszewska, K.; Fabianowska-Majewska, K. The role of sulforaphane in epigenetic mechanisms, including interdependence between histone modification and DNA methylation. Int. J. Mol. Sci. 2015, 16, 29732–29743. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Navarro, S.L.; Li, F.; Lampe, J.W. Mechanisms of action of isothiocyanates in cancer chemoprevention: An update. Food Funct. 2011, 2, 579–587. [Google Scholar] [CrossRef] [PubMed]
- Kulis, M.; Esteller, M. DNA methylation and cancer. Adv. Genet. 2010, 70, 27–56. [Google Scholar] [CrossRef]
- Romero-Garcia, S.; Prado-Garcia, H.; Carlos-Reyes, A. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors. Front. Oncol. 2020, 10, 1152. [Google Scholar] [CrossRef]
- Meeran, S.M.; Patel, S.N.; Tollefsbol, T.O. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS ONE 2010, 5, e11457. [Google Scholar] [CrossRef]
- Izzotti, A.; Larghero, P.; Cartiglia, C.; Longobardi, M.; Pfeffer, U.; Steele, V.E.; De Flora, S. Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 2010, 31, 894–901. [Google Scholar] [CrossRef] [Green Version]
- Li, F.; Hullar, M.A.J.; Schwarz, Y.; Lampe, J.W. Human gut bacterial communities are altered by addition of cruciferous vegetables to a controlled fruit- and vegetable-free diet. J. Nutr. 2009, 139, 1685–1691. [Google Scholar] [CrossRef] [PubMed]
- Kaczmarek, J.L.; Liu, X.; Charron, C.S.; Novotny, J.A.; Jeffery, E.H.; Seifried, H.E.; Ross, S.A.; Miller, M.J.; Swanson, K.S.; Holscher, H.D. Broccoli consumption affects the human gastrointestinal microbiota. J. Nutr. Biochem. 2019, 63, 27–34. [Google Scholar] [CrossRef]
- Wu, Y.; Shen, Y.; Zhu, Y.; Mupunga, J.; Zou, L.; Liu, C.; Liu, S.; Mao, J. Broccoli ingestion increases the glucosinolate hydrolysis activity of microbiota in the mouse gut. Int. J. Food Sci. Nutr. 2019, 70, 585–594. [Google Scholar] [CrossRef] [PubMed]
- Higdon, J.V.; Delage, B.; Williams, D.E.; Dashwood, R.H. Cruciferous vegetables and human cancer risk: Epidemiologic evidence and mechanistic basis. Pharm. Res. 2007, 55, 224–236. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Baenas, N.; Marhuenda, J.; García-Viguera, C.; Zafrilla, P.; Moreno, D.A. Influence of Cooking Methods on Glucosinolates and Isothiocyanates Content in Novel Cruciferous Foods. Foods 2019, 8, 257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rein, M.J.; Renouf, M.; Cruz-Hernandez, C.; Actis-Goretta, L.; Thakkar, S.K.; da Silva Pinto, M. Bioavailability of bioactive food compounds: A challenging journey to bioefficacy. Br. J. Clin. Pharmacol. 2013, 75, 588–602. [Google Scholar] [CrossRef] [Green Version]
- Dima, C.; Assadpour, E.; Dima, S.; Jafari, S.M. Bioavailability and bioaccessibility of food bioactive compounds; overview and assessment by in vitro methods. Comprehnsive Rev. Food Sci. Food Saf. 2020, 9, 2862–2884. [Google Scholar] [CrossRef]
- Vallejo, F.; Gil-Izquierdo, A.; Pérez-Vicente, A.; García-Viguera, C. In Vitro Gastrointestinal Digestion Study of Broccoli Inflorescence Phenolic Compounds, Glucosinolates, and Vitamin C. J. Agric. Food Chem. 2004, 52, 135–138. [Google Scholar] [CrossRef]
- Esteve, M. Mechanisms Underlying Biological Effects of Cruciferous Glucosinolate-Derived Isothiocyanates/Indoles: A Focus on Metabolic Syndrome. Front. Nutr. 2020, 7, 111. [Google Scholar] [CrossRef]
- Barba, F.J.; Nikmaram, N.; Roohinejad, S.; Khelfa, A.; Zhu, Z.; Koubaa, M. Bioavailability of Glucosinolates and Their Breakdown Products: Impact of Processing. Front Nutr. 2016, 16, 3–24. [Google Scholar] [CrossRef] [Green Version]
- Puangkam, K.; Muanghorm, W.; Konsue, N. Stability of Bioactive Compounds and Antioxidant Activity of Thai Cruciferous Vegetables During In Vitro Digestion. Curr. Res. Nutr. Food Sci. 2017, 5, 100–108. [Google Scholar] [CrossRef]
- Volf, I.; Ignat, I.; Neamtu, M.; Popa, V.I. Thermal stability, antioxidant activity, and photo-oxidation of natural polyphenols. Chem. Pap. 2014, 68, 121–129. [Google Scholar] [CrossRef]
- Matusheski, N.V.; Juvik, J.A.; Jeffery, E.H. Heating decreases epithiospecifier pro- tein activity and increases sulforaphane formation in broccoli. Phytochemistry 2004, 65, 1273–1281. [Google Scholar] [CrossRef]
- Zanoni, F.; Primiterra, M.; Angeli, N.; Zoccatelli, G. Microencapsulation by spray-drying of polyphenols extracted from red chicory and red cabbage: Effects on stability and color properties. Food Chem. 2020, 307, 125535. [Google Scholar] [CrossRef]
- Li, J. Chapter 18: The Use of Starch-Based Materials for Microencapsulation. In Microencapsulation in the Food Industry; Gaonkar, A.G., Vasisht, N., Khare, A.R., Sobel, R., Eds.; Academic Press: London, UK, 2014; pp. 195–210. ISBN 9780124045682. [Google Scholar] [CrossRef]
- Radünz, M.; Dos Santos Hackbart, H.C.; Pontes Bona, N.; Stark Pedra, N.; Hoffmann, J.F.; Stefanello, F.M.; Da Rosa Zavareze, E. Glucosinolates and phenolic compounds rich broccoli extract: Encapsulation by electrospraying and antitumor activity against glial tumor cells. Colloids Surf. B Biointerfaces 2020, 192, 111020. [Google Scholar] [CrossRef]
- Wang, Q.; Yin, L.; Padua, G.W. Effect of Hydrophilic and Lipophilic Compounds on Zein Microstructures. Food Biophys. 2008, 3, 174–181. [Google Scholar] [CrossRef]
- Luo, Y.; Wang, T.T.Y.; Teng, Z.; Chen, P.; Sun, J.; Wang, Q. Encapsulation of indole-3-carbinol and 3,3′-diindolylmethane in zein/carboxymethyl chitosan nanoparticles with controlled release property and improved stability. Food Chem. 2013, 139, 224–230. [Google Scholar] [CrossRef]
- Bradlow, H.L.; Zeligs, M.A. Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments. Vivo 2010, 24, 387–391. [Google Scholar]
- Zambrano, V.; Bustos, R.; Mahn, A. Insights about stabilization of sulforaphane through microencapsulation. Helyon 2019, 5, e02951. [Google Scholar] [CrossRef]
- Wu, H.; Liang, H.; Yuan, Q.; Wang, T.; Yan, X. Preparation and stability investigation of the inclusion complex of sulforaphane with hydroxypropyl- β-cyclodextrin. Carbohydr. Polym. 2010, 82, 613–617. [Google Scholar] [CrossRef]
- Wu, Y.; Mao, J.; Mei, L.; Liu, S. Kinetic studies of the thermal degradation of sulforaphane and its hydroxypropyl-β-cyclodextrin inclusion complex. Food Res. Int. 2013, 53, 529–533. [Google Scholar] [CrossRef]
- Wu, Y.; Zou, L.; Mao, J.; Huang, J.; Liu, S. Stability and encapsulation efficiency of sulforaphane microencapsulated by spray drying. Carbohydr. Polym. 2014, 102, 497–503. [Google Scholar] [CrossRef] [PubMed]
- Kriti, S.; Rizwanullah, M.; Kohli, K. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: In vitro, ex vivo and in vivo assessments. Artif. Cells Nanomed. Biotechnol. 2018, 46, 15–31. [Google Scholar] [CrossRef] [Green Version]
- Garcia-Ibañez, P.; Roses, C.; Agudelo, A.; Milagro, F.I.; Barceló, A.M.; Viadel, B.; Nieto, J.A.; Moreno, D.A.; Carvajal, M. The Influence of Red Cabbage Extract Nanoencapsulated with Brassica Plasma Membrane Vesicles on the Gut Microbiome of Obese Volunteers. Foods 2021, 10, 1038. [Google Scholar] [CrossRef] [PubMed]
- Garcia-Ibañez, P.; Moreno, D.A.; Carvajal, M. Increased stability of Bimi® glucosinolates by bioencapsulation. In Proceedings of the 1st International Electronic Conference on Food Science and Functional Foods, Online, 10–25 November 2020; MDPI: Basel, Switzerland, 2020. [Google Scholar] [CrossRef]
Energy (Kcal) | Water Content (g) | Carbohydrates (g) | Fat (g) | Fibre (g) | Protein (g) | Minerals (mg) | Vitamins | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Ca | Fe | K | Mg | C (mg) | Folate (µg) | |||||||
Broccoli | 34 | 89.3 | 6.6 | 0.37 | 2.6 | 2.8 | 47 | 0.7 | 316 | 21 | 89.2 | 63 |
Brussels Sprouts | 43 | 86 | 9 | 0.3 | 3.8 | 3.4 | 42 | 1.4 | 389 | 23 | 85 | 61 |
Cabbage | 25 | 92.2 | 5.8 | 0.1 | 2.5 | 1.3 | 40 | 0.5 | 170 | 12 | 36.6 | 43 |
Cauliflower | 25 | 92 | 5 | 0.3 | 2 | 1.9 | 22 | 0.4 | 299 | 15 | 48.2 | 57 |
Kale | 49 | 84 | 8.8 | 0.9 | 3.6 | 4.3 | 150 | 1.5 | 491 | 47 | 120 | 141 |
Radish | 16 | 95.3 | 3.4 | 0.1 | 1.6 | 0.7 | 25 | 0.3 | 233 | 10 | 14.8 | 25 |
Turnip | 28 | 91.9 | 6.4 | 0.1 | 1.8 | 1.2 | 30 | 0.3 | 191 | 11 | 21 | 15 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Melim, C.; Lauro, M.R.; Pires, I.M.; Oliveira, P.J.; Cabral, C. The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics. Pharmaceutics 2022, 14, 190. https://doi.org/10.3390/pharmaceutics14010190
Melim C, Lauro MR, Pires IM, Oliveira PJ, Cabral C. The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics. Pharmaceutics. 2022; 14(1):190. https://doi.org/10.3390/pharmaceutics14010190
Chicago/Turabian StyleMelim, Catarina, Maria R. Lauro, Isabel M. Pires, Paulo J. Oliveira, and Célia Cabral. 2022. "The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics" Pharmaceutics 14, no. 1: 190. https://doi.org/10.3390/pharmaceutics14010190
APA StyleMelim, C., Lauro, M. R., Pires, I. M., Oliveira, P. J., & Cabral, C. (2022). The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics. Pharmaceutics, 14(1), 190. https://doi.org/10.3390/pharmaceutics14010190